StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd

Bullboard Posts

Comment by Noloon Nov 08, 2019 9:50am

78 Views

Post# 30326762

RE:Stage .005 Coming!!

rydnhi wrote: What a joke, then the misleading crooks will begin their orchestrated pump campaign. one more time. rinse repeat rinse repeat............

If you strongly believe that this is what's really happening, then follow them on the ride up. Piggy back on their purported pump and make some cash quickly.

It's a volatile stock with a lot of trading activity. So don't expect a perfect upward slope on the graph.

Bullboard Posts

Rig Count Soars as Utilization Surpasses Industry Averages